Abstract
Annual Review of Public Health
Vol. 26: 191-212 (Volume publication date April 2005)
(doi:10.1146/annurev.publhealth.26.021304.144536)
First published online as a Review in Advance on December 8, 2004 THE PUBLIC HEALTH IMPACT OF PRION DISEASES
Ermias D. Belay and *Lawrence B. Schonberger* Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333; email:
EBelay@cdc.gov
Several prion disease[img]/na101/home/literatum/ar/journals/entities/2013.gif[/img]related human health risks from an exogenous source can be identified in the United States, including the iatrogenic transmission of Creutzfeldt-Jakob disease (CJD), the possible occurrence of variant CJD (vCJD), and potential zoonotic transmission of chronic wasting disease (CWD). Although cross-species transmission of prion diseases seems to be limited by an apparent "species barrier," the occurrence of bovine spongiform encephalopathy (BSE) and its transmission to humans indicate that animal prion diseases can pose a significant public health risk. Recent reports of secondary person-to-person spread of vCJD via blood products and detection of vCJD transmission in a patient heterozygous at codon 129 further illustrate the potential public health impacts of BSE.
__________________
Mr. Jan B. Wade
Blood Management Consultant
Enhance Outcomes - Control Cost
For Information Call - 360 296-1807
Email
You are currently accessing this Site as a guest. Please login or register by clicking Here
Linear Mode
